Oral bisphosphonate use and breast cancer incidence in postmenopausal women.

Publication Type:

Journal Article

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 28, Issue 22, p.3582-90 (2010)

Keywords:

2010, Administration, Oral, Aged, Alendronate, Bone Density Conservation Agents, Breast Neoplasms, Center-Authored Paper, Diphosphonates, Female, Humans, Incidence, Middle Aged, Public Health Sciences Division, RISK

Abstract:

Emerging clinical evidence suggests intravenous bisphosphonates may inhibit breast cancer while oral bisphosphonates have received limited evaluation regarding breast cancer influence.